[
  {
    "ts": null,
    "headline": "Analyst Says Merck (MRK) is ‘Really Cheap’ But Warns About Potential ‘Bad News’",
    "summary": "Bill Stone, Glenview Trust Company chief investment officer, mentioned his bullish take on Merck (NYSE:MRK) during a recent program on CNBC and explained the potential risks and rewards tied to the stock: “There’s good news and bad news. The good news is they own Keytruda, which has been just a phenomenal success in treating many […]",
    "url": "https://finnhub.io/api/news?id=1d676a9d7349e778e05431abc16084ea7253c0d3e593b886fcb7ddbb9abd3e35",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749129595,
      "headline": "Analyst Says Merck (MRK) is ‘Really Cheap’ But Warns About Potential ‘Bad News’",
      "id": 135063810,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Bill Stone, Glenview Trust Company chief investment officer, mentioned his bullish take on Merck (NYSE:MRK) during a recent program on CNBC and explained the potential risks and rewards tied to the stock: “There’s good news and bad news. The good news is they own Keytruda, which has been just a phenomenal success in treating many […]",
      "url": "https://finnhub.io/api/news?id=1d676a9d7349e778e05431abc16084ea7253c0d3e593b886fcb7ddbb9abd3e35"
    }
  },
  {
    "ts": null,
    "headline": "Top Dividend Stocks To Consider In June 2025",
    "summary": "Over the last 7 days, the United States market has risen by 1.4%, contributing to a 12% increase over the past year, with earnings forecasted to grow by 15% annually. In this environment of growth and optimism, selecting dividend stocks that offer consistent income and potential for capital appreciation can be a strategic way to enhance an investment portfolio.",
    "url": "https://finnhub.io/api/news?id=3bf827b671fd01a2bf05e3382e78c8c249497f026707bb49c976cf6ccf155653",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749123110,
      "headline": "Top Dividend Stocks To Consider In June 2025",
      "id": 135045205,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Over the last 7 days, the United States market has risen by 1.4%, contributing to a 12% increase over the past year, with earnings forecasted to grow by 15% annually. In this environment of growth and optimism, selecting dividend stocks that offer consistent income and potential for capital appreciation can be a strategic way to enhance an investment portfolio.",
      "url": "https://finnhub.io/api/news?id=3bf827b671fd01a2bf05e3382e78c8c249497f026707bb49c976cf6ccf155653"
    }
  },
  {
    "ts": null,
    "headline": "Procter & Gamble, Walmart share losses contribute to Dow's nearly 125-point fall",
    "summary": "Procter & Gamble, Walmart share losses contribute to Dow's nearly 125-point fall",
    "url": "https://finnhub.io/api/news?id=f31f6385c59c5e52b5fdcb3a461dc380c413afe9433d8a19b805f4bd9f4dc5ff",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749116760,
      "headline": "Procter & Gamble, Walmart share losses contribute to Dow's nearly 125-point fall",
      "id": 135047385,
      "image": "",
      "related": "MRK",
      "source": "MarketWatch",
      "summary": "Procter & Gamble, Walmart share losses contribute to Dow's nearly 125-point fall",
      "url": "https://finnhub.io/api/news?id=f31f6385c59c5e52b5fdcb3a461dc380c413afe9433d8a19b805f4bd9f4dc5ff"
    }
  },
  {
    "ts": null,
    "headline": "China's Biotech Revolution Rolls Forward To The Global Frontiers Of Medical Therapeutics",
    "summary": "In the past five years, China has leaped from fast follower to global pioneer in drug discovery and development. Click to read.",
    "url": "https://finnhub.io/api/news?id=3c697230053421deb8e8262c7e1872c8494cfb3d07ebb42a163e485414df703f",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749111000,
      "headline": "China's Biotech Revolution Rolls Forward To The Global Frontiers Of Medical Therapeutics",
      "id": 135045218,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1389605524/image_1389605524.jpg?io=getty-c-w1536",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "In the past five years, China has leaped from fast follower to global pioneer in drug discovery and development. Click to read.",
      "url": "https://finnhub.io/api/news?id=3c697230053421deb8e8262c7e1872c8494cfb3d07ebb42a163e485414df703f"
    }
  }
]